AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas

Matthew L. Bush, Janet Oblinger, Victoria Brendel, Griffin Santarelli, Jie Huang, Elena M. Akhmametyeva, Sarah S. Burns, Justin Wheeler, Jeremy Davis, Charles W. Yates, Abhik R. Chaudhury, Samuel Kulp, Ching Shih Chen, Long Sheng Chang, D. Bradley Welling, Abraham Jacob

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas'. Together they form a unique fingerprint.

Medicine & Life Sciences